{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:20:44Z","timestamp":1785252044404,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Deep vein thrombosis (DVT) of the legs is a rare but clinically important complication of <jats:italic>Chlamydia psittaci<\/jats:italic> pneumonia. We report a case of a 51-year-old man who was admitted to the hospital with fever, cough, and dyspnea. Next-generation sequencing confirmed the diagnosis of <jats:italic>Chlamydia psittaci<\/jats:italic> pneumonia. His D-dimer level was elevated on admission, and ultrasound confirmed DVT in the legs. The patient was treated with intravenous doxycycline for the infection and rivaroxaban as an anticoagulant. His condition gradually improved and he was discharged after making a full recovery. In this paper, we explore the potential association between <jats:italic>Chlamydia psittaci<\/jats:italic> infection and venous thrombosis, as well as clinical management strategies.<\/jats:p>","DOI":"10.3389\/fmed.2025.1527556","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:10:17Z","timestamp":1740460217000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe Chlamydia psittaci pneumonia complicated by deep vein thrombosis: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Anbing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqiong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/IDR.S355024","article-title":"Severe Chlamydia psittaci pneumonia complicated by rhabdomyolysis: A case series.","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect Drug Resist."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e29238","DOI":"10.1097\/MD.0000000000029238","article-title":"Clinical characteristics of 14 cases of severe Chlamydia psittaci pneumonia diagnosed by metagenomic next-generation sequencing: A case series.","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)."},{"key":"B3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism.","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.2147\/IDR.S435246","article-title":"Chlamydia psittaci pneumonia-induced pulmonary thrombosis: A case report.","volume":"16","author":"Fang","year":"2023","journal-title":"Infect Drug Resist."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2147\/IDR.S393256","article-title":"Chlamydia psittaci pneumonia complicated with lower extremity atherosclerotic occlusive disease.","volume":"16","author":"He","year":"2023","journal-title":"Infect Drug Resist."},{"key":"B6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1186\/s12885-023-11424-x","article-title":"Risk of venous thromboembolism in patients undergoing gastric cancer surgery: A systematic review and meta-analysis.","volume":"23","author":"Xiang","year":"2023","journal-title":"BMC Cancer."},{"key":"B7","doi-asserted-by":"crossref","first-page":"e1085","DOI":"10.1002\/hsr2.1085","article-title":"Venous thromboembolism in viral diseases: A comprehensive literature review.","volume":"6","author":"Zerangian","year":"2023","journal-title":"Health Sci Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12879-020-4918-y","article-title":"Animal sources for zoonotic transmission of psittacosis: A systematic review.","volume":"20","author":"Hogerwerf","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12941-023-00631-w","article-title":"Epidemiological and clinical characteristics of psittacosis among cases with complicated or atypical pulmonary infection using metagenomic next-generation sequencing: A multi-center observational study in China.","volume":"22","author":"Huang","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob."},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.thromres.2017.01.008","article-title":"Hospitalization with infection and incident venous thromboembolism: The ARIC study.","volume":"151","author":"Cowan","year":"2017","journal-title":"Thromb Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/resp.12501","article-title":"Association between pneumococcal pneumonia and venous thromboembolism in hospitalized patients: A nationwide population-based study.","volume":"20","author":"Chen","year":"2015","journal-title":"Respirology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ije\/dyr012","article-title":"Recent respiratory infection and risk of venous thromboembolism: Case-control study through a general practice database.","volume":"40","author":"Clayton","year":"2011","journal-title":"Int J Epidemiol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"key":"B14","doi-asserted-by":"crossref","first-page":"e2111788","DOI":"10.1001\/jamanetworkopen.2021.11788","article-title":"Trends in venous thromboembolism anticoagulation in patients hospitalized with COVID-19.","volume":"4","author":"Vaughn","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B15","first-page":"1119","article-title":"[Preliminary progress in the study of the relationship between COVID-19 infection and partial arterial or venous diseases].","volume":"61","author":"Ren","year":"2023","journal-title":"Zhonghua Wai Ke Za Zhi."},{"key":"B16","doi-asserted-by":"publisher","first-page":"115321","DOI":"10.1016\/j.biopha.2023.115321","article-title":"Role of SARS-CoV-2 and ACE2 in the pathophysiology of peripheral vascular diseases.","volume":"166","author":"Tanzadehpanah","year":"2023","journal-title":"Biomed Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/JIR.S258839","article-title":"Microbial modulation of coagulation disorders in venous thromboembolism.","volume":"13","author":"Lichota","year":"2020","journal-title":"J Inflamm Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"16299","DOI":"10.1038\/s41598-020-73011-5","article-title":"Presence of bacterial DNA in thrombotic material of patients with myocardial infarction.","volume":"10","author":"Pi\u00f1on-Esteban","year":"2020","journal-title":"Sci Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12887-023-04188-7","article-title":"retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia.","volume":"23","author":"Song","year":"2023","journal-title":"BMC Pediatr."},{"key":"B20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jtha.2023.07.020","article-title":"Thromboinflammation in acute injury: Infections, heatstroke, and trauma.","volume":"22","author":"Iba","year":"2024","journal-title":"J Thromb Haemost."},{"key":"B21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0035-1556729","article-title":"Chronic infection and venous thromboembolic disease.","volume":"41","author":"Epaulard","year":"2015","journal-title":"Semin Thromb Hemost."},{"key":"B22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/ATVBAHA.119.313137","article-title":"IL (interleukin)-6 contributes to deep vein thrombosis and is negatively regulated by miR-338-5p.","volume":"40","author":"Zhang","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1111\/jth.12742","article-title":"Inflammation markers and incident venous thromboembolism: The REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.","volume":"12","author":"Olson","year":"2014","journal-title":"J Thromb Haemost."},{"key":"B24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1161\/01.RES.0000163015.67711.AB","article-title":"Activation of inflammation and coagulation after infusion of C-reactive protein in humans.","volume":"96","author":"Bisoendial","year":"2005","journal-title":"Circ Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.atherosclerosis.2005.11.006","article-title":"C-reactive protein 3\u2019 UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism.","volume":"188","author":"Vormittag","year":"2006","journal-title":"Atherosclerosis."},{"key":"B27","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa1909159","article-title":"Diagnosis of pulmonary embolism with D-dimer adjusted to clinical probability.","volume":"381","author":"Kearon","year":"2019","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.3949\/ccjm.84.s3.04","article-title":"Update on the management of venous thromboembolism.","volume":"84","author":"Bartholomew","year":"2017","journal-title":"Cleve Clin J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: A randomised, controlled, phase 3 trial.","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1527556\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:10:25Z","timestamp":1740460225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1527556\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":29,"alternative-id":["10.3389\/fmed.2025.1527556"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1527556","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"article-number":"1527556"}}